Impact of Patient Support From Medical Staff on the Adherence to Therapy With PegIntron Plus Rebetol.
Phase of Trial: Phase IV
Latest Information Update: 16 Dec 2013
At a glance
- Drugs Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 21 Jul 2008 New trial record.